Monosaccharides - Glyconutrient, Sugars that Heal

Glyconutritionals - Our body requires 8 different essential glyconutritionals but only 2 of those are found in any amount in our modern day diets. This is why we should take a complete glyconutrient supplement. Without it, our body will be unable to properly build glycoproteins, which can cause great detriment to our health. At this Glyconutrients Website, you will find all the up-to-date information on glyconutritionals. -

Asbestos Indictment Rallies Montanans
They're getting ready for the Asbestos Health Fair in this old mining town. Posters promise "Door Prizes!!" and "Blood draw to participate in ongoing research!" Companies that sell home oxygen supplies will send reps. Doctors and researchers will be here. There will be consultants to help asbestosis victims apply for ...

Deaths from mesothelioma will peak within ten years?
Deaths from mesothelioma, an asbestos-related lung cancer, will peak within ten years in the UK and then fall to a much lower level, according to new figures published in this week's British Journal of Cancer. Mesothelioma is a type of cancer in the lining of the lungs or the lining ...

Allos Therapeutics, Inc. (ALTH) Initiates Phase 1 PDX Study
Allos Therapeutics, Inc. today announced the initiation of a Phase 1 dose escalation study of its investigational drug PDX (pralatrexate) with vitamin B12 and folic acid supplementation in patients with previously-treated (Stage IIIB-IV) advanced non-small cell lung cancer (NSCLC). This open-label, non-randomized study will seek to enroll one to six ...

Crane Q4 profit rises on gains, abandons asbestos deal
SAN FRANCISCO (CBS.MW) -- Crane Co., an industrial products maker, late Monday reported a higher fourth-quarter profit, helped by a one-time gain resulting from the termination of its planned asbestos settlement. Crane Q4 profit rises on gains, abandons asbestos deal The Stamford, Conn.-based company posted ...

Malignant Pleural Mesothelioma European Prognosis Score Validated
European Prognosis Score Validated in Malignant Pleural Mesothelioma: A recent article in the Journal of Clinical Oncology reports that the current model for determining the prognosis for malignant pleural mesothelioma (MPM) is a valid tool for determining high and low-risk patients for clinical trial participation. The current model for determining the ...